US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

IMMP

Immutep (IMMP)

Immutep Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMMP

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/24	21 : 00	GlobeNewswire Inc.	Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B	NASDAQ:IMMP	Immutep Ltd
2024/04/18	21 : 00	GlobeNewswire Inc.	Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761	NASDAQ:IMMP	Immutep Ltd
2024/04/17	21 : 00	GlobeNewswire Inc.	Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer	NASDAQ:IMMP	Immutep Ltd
2024/03/05	22 : 00	GlobeNewswire Inc.	Immutep Announces First Clinical Data from 90mg Dosing of Efti	NASDAQ:IMMP	Immutep Ltd
2024/01/31	06 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMMP	Immutep Ltd
2024/01/30	22 : 00	GlobeNewswire Inc.	Immutep Quarterly Activities Report Q2 FY24	NASDAQ:IMMP	Immutep Ltd
2024/01/04	22 : 00	GlobeNewswire Inc.	First Patient Dosed in Trial Evaluating Efti and the Anti-PD-L1 Therapy BAVENCIO® in Metastatic Urothelial Cancer	NASDAQ:IMMP	Immutep Ltd
2023/12/21	22 : 00	GlobeNewswire Inc.	Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer	NASDAQ:IMMP	Immutep Ltd
2023/12/21	20 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMMP	Immutep Ltd
2023/12/07	22 : 00	GlobeNewswire Inc.	Immutep Receives A$2.6 million R&D Tax Incentive from French Government	NASDAQ:IMMP	Immutep Ltd
2023/11/22	22 : 00	GlobeNewswire Inc.	Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial	NASDAQ:IMMP	Immutep Ltd
2023/11/09	22 : 00	GlobeNewswire Inc.	Immutep Completes Enrollment in TACTI-003 Phase IIb Trial of Efti and KEYTRUDA® in First Line Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma	NASDAQ:IMMP	Immutep Ltd
2023/11/06	22 : 00	GlobeNewswire Inc.	Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer	NASDAQ:IMMP	Immutep Ltd
2023/11/04	01 : 00	GlobeNewswire Inc.	Immutep Announces New Biomarker Data from TACTI-002 Phase II in First Line Non-Small Cell Lung Cancer	NASDAQ:IMMP	Immutep Ltd
2023/11/03	19 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMMP	Immutep Ltd
2023/11/02	21 : 00	GlobeNewswire Inc.	Immutep to Participate in November Investor Events	NASDAQ:IMMP	Immutep Ltd
2023/10/31	21 : 00	GlobeNewswire Inc.	Immutep Quarterly Activities Report Q1 FY24	NASDAQ:IMMP	Immutep Ltd
2023/10/25	21 : 00	GlobeNewswire Inc.	Immutep receives ~A$1.13 million R&D Tax Incentive	NASDAQ:IMMP	Immutep Ltd
2023/10/25	19 : 07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMMP	Immutep Ltd
2023/10/24	21 : 00	GlobeNewswire Inc.	Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023	NASDAQ:IMMP	Immutep Ltd
2023/10/24	19 : 35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMMP	Immutep Ltd
2023/10/23	21 : 00	GlobeNewswire Inc.	Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer	NASDAQ:IMMP	Immutep Ltd
2023/10/16	21 : 00	GlobeNewswire Inc.	Immutep Announces Publication of Abstracts at ESMO Congress 2023	NASDAQ:IMMP	Immutep Ltd
2023/10/03	21 : 00	GlobeNewswire Inc.	Immutep Announces Abstract Accepted for Presentation at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting	NASDAQ:IMMP	Immutep Ltd
2023/09/21	21 : 00	GlobeNewswire Inc.	Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Trial Use	NASDAQ:IMMP	Immutep Ltd
2023/09/05	22 : 00	GlobeNewswire Inc.	Immutep to Participate in September Investor Conferences	NASDAQ:IMMP	Immutep Ltd
2023/08/01	21 : 00	GlobeNewswire Inc.	Immutep Receives Positive Scientific Advice from European Medicines Agency	NASDAQ:IMMP	Immutep Ltd
2023/07/31	21 : 00	GlobeNewswire Inc.	Immutep Quarterly Activities Report Q4 FY23	NASDAQ:IMMP	Immutep Ltd
2023/07/31	21 : 00	GlobeNewswire Inc.	Immutep to Present Overall Survival Data in 1st Line Non-Small Cell Lung Cancer Accepted for Oral Presentation at ESMO Congress 2023	NASDAQ:IMMP	Immutep Ltd
2023/07/28	21 : 00	GlobeNewswire Inc.	First Patient Dosed in Chemotherapy-Free Triple Combination Phase II Trial Targeting Soft Tissue Sarcoma	NASDAQ:IMMP	Immutep Ltd

Showing the most relevant articles for your search:NASDAQ:IMMP

1 2 3 4 5 6 7 8 9 10 次へ >>

Verizon Communications

Financial Select Sector

Gold vs US Dollar

Deutsche Telekom (QX)

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約